Short answer
STI testing is routine preventive care for sexually active people. Many STIs can have no symptoms, so testing decisions should be based on age, partners, pregnancy, sexual practices, symptoms, exposure concerns, body sites, local STI rates, and risk factors rather than symptoms alone.
The best test is not just the biggest panel. It is the test that matches the infection, the body site, the time since possible exposure, and the follow-up plan if a result is positive, negative but too early, unclear, or discordant.
What common STI tests cover
| Infection or question | Common testing approach | Important caveat |
|---|---|---|
| HIV | Blood or oral-fluid tests depending on setting and test type. | Timing matters because HIV tests have window periods; NAT, lab antigen/antibody, rapid tests, and self-tests answer different timing questions. |
| Chlamydia | NAAT on urine or swab sample, depending on anatomy and exposure site. | CDC notes vaginal swabs and first-catch urine are common urogenital specimens, but rectal or throat testing may matter based on exposure. |
| Gonorrhea | NAAT on urine or swab sample, including genital, rectal, or pharyngeal sites when appropriate. | CDC notes patient-collected samples can be used for urine, vaginal, rectal, and oropharyngeal swabs in clinical settings when instructions are provided. |
| Syphilis | Usually blood testing with nontreponemal and treponemal tests used in an algorithm. | RPR or VDRL alone is not the whole story; reactive screening often needs confirmatory or algorithm-based interpretation. |
| Hepatitis B and C | Blood tests; hepatitis B often needs a panel, and hepatitis C screening often starts with antibody testing followed by RNA if reactive. | Vaccination history, pregnancy, injection exposure, and prior infection change interpretation. |
| Herpes, HPV, trichomoniasis, Mgen, BV, yeast, UTI overlap | Depends on symptoms, exam, swab site, Pap/HPV screening, urine studies, or targeted molecular tests. | These are often not automatically included in routine STI panels unless specifically ordered or clinically indicated. |
Who should test and how often
- CDC says everyone ages 13 to 64 should be tested at least once for HIV.
- CDC says all sexually active women younger than 25 should be tested yearly for chlamydia and gonorrhea.
- CDC says some women age 25 and older should test yearly for chlamydia and gonorrhea based on risk factors such as new or multiple partners or a partner with an STI.
- CDC says sexually active gay, bisexual, and other men who have sex with men should test at least yearly for syphilis, chlamydia, gonorrhea, and HIV, with more frequent testing for some people.
- CDC says pregnant people should be tested early in pregnancy for syphilis, HIV, hepatitis B, and hepatitis C, with some people needing repeat testing and chlamydia or gonorrhea testing.
- Anyone with symptoms, a partner with an STI, shared injection equipment, a new partner, multiple partners, sexual assault exposure, or concern about a specific body site may need individualized testing sooner.
Body-site testing: urine is not always enough
Urine testing can be useful for some genital chlamydia and gonorrhea questions, but it does not test every site. If oral sex, receptive anal sex, shared toys, or symptoms at a specific site are part of the story, ask whether throat, rectal, vaginal, cervical, urethral, lesion, or blood testing is needed.
This is one of the biggest practical gaps in STI testing. A negative urine chlamydia or gonorrhea result does not automatically rule out a throat or rectal infection if those sites were exposed and not tested.
Window periods, symptoms, and repeat testing
Testing too early can give false reassurance. HIV tests have well-defined window periods by test type, and syphilis blood tests can also require follow-up when timing or results are unclear. Chlamydia and gonorrhea NAATs can detect infection at exposed sites, but repeat testing may still be recommended after treatment or when a recent exposure, symptoms, or partner diagnosis changes the question.
Symptoms should change the plan. Burning, discharge, pelvic pain, testicular pain, sores, ulcers, rash, fever, rectal pain, rectal discharge, or eye symptoms can require clinician evaluation rather than a routine screening panel alone.
Self-tests, self-collection, and clinic testing
CDC describes three broad routes: testing by a health care provider, self-testing that can produce a direct result, and self-collection where a sample is mailed or sent to a lab. FDA-authorized options have expanded, including home sample collection for chlamydia and gonorrhea and an at-home first step for syphilis diagnosis.
At-home access can reduce stigma and make testing easier, but it does not remove the need to check what is actually included. Ask whether the kit covers the right infection, body site, specimen type, confirmatory testing, treatment access, partner notification, reporting, and follow-up if the result is positive or unclear.
What a full STI panel can miss
"Full STI panel" is not a medical standard. One clinic or online lab may mean HIV, syphilis, chlamydia, and gonorrhea. Another may add hepatitis, trichomoniasis, herpes antibodies, or other tests. The phrase can still miss throat or rectal sites, window periods, lesion swabs, HPV and Pap screening, Mycoplasma genitalium, BV or yeast testing, UTI testing, pregnancy testing, and confirmatory syphilis or HIV follow-up.
A better question than "Is this full?" is "Does this panel match my body sites, symptoms, exposure timing, pregnancy status, prevention medications, and follow-up needs?"
When follow-up matters more
Follow-up matters more when symptoms, timing, or body-site exposure mean a routine panel is not enough. In that situation, the next decision is often whether to add throat, rectal, lesion, pregnancy, HIV, hepatitis, or repeat-window testing rather than relying on a generic STI panel label.
Questions to ask before choosing a test
- Which infections are included, and which are not?
- Does the test match the body sites where exposure happened: genital, throat, rectal, skin, blood, or lesion?
- Is the timing right, or should testing be repeated after a window period?
- Will a positive or unclear result trigger confirmatory testing, treatment, partner notification, and reporting when required?
- If I have symptoms, do I need an exam, lesion swab, urine culture, pregnancy test, pelvic exam, or urgent care?
- If I use PrEP, recently used PEP, am pregnant, or have a partner with an STI, do I need a specific schedule?
- Is confidential or low-cost testing available nearby through a clinic, health department, Title X clinic, or CDC GetTested listing?
FAQ
Can STIs have no symptoms?
Yes. CDC emphasizes that many sexually transmitted infections can have no symptoms, so testing can matter even when someone feels well.
Is urine enough for STI testing?
Sometimes, but not always. Urine can be used for some genital chlamydia and gonorrhea testing, but throat or rectal exposure may need throat or rectal swabs, and blood tests are used for infections such as HIV and syphilis.
What is the difference between STI self-testing and self-collection?
A self-test is completed by the person and can produce results directly. Self-collection means the person collects a sample, such as a swab, urine, or blood, and sends it to a laboratory for results.
Does a full STI panel test for everything?
No. A full STI panel is a marketing phrase, not a universal standard. Panels vary and may miss body sites, window periods, herpes lesion swabs, HPV or Pap screening, trichomoniasis, Mycoplasma genitalium, hepatitis tests, or confirmatory syphilis testing.
When should STI testing be repeated?
Repeat testing depends on the infection, test type, exposure timing, symptoms, pregnancy, PrEP or PEP use, and whether a partner has a known STI. HIV and syphilis blood tests have timing issues, and chlamydia or gonorrhea retesting can be recommended after treatment in some situations.
Where can someone find low-cost STI testing?
CDC GetTested can help locate nearby HIV, STI, and hepatitis testing. Local health departments, STI clinics, Title X clinics, community health centers, and some primary-care offices may also offer confidential or low-cost testing.